Discovery of DS-1093a: An oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of renal anemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of DS-1093a: An oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of renal anemia

Published:2024-10 Issue: Volume:111 Page:129891
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Tanaka Naoki,Fukuda Takeshi,Takano Rieko,Sasaki Koji,Tsuji Takashi,Goto Riki,Kuribayashi Takeshi,Yamaguchi Kyoji,Niitsu Yoichi,Ishii Ken,Hashimoto Masami,Takahashi Shinichi,Obayashi Hisakuni

Publisher

Elsevier BV

Reference18 articles.

1. Physiology and pharmacology of erythropoietin;Jelkmann;Transfus Med Hemother,2013

2. Erythropoietin: physiology and pharmacology update;Fisher;Exp Hematol,2003

3. Development and characterization of novel erythropoiesis stimulating protein (NESP);Egrie;Br J Cancer,2001

4. The effect of erythropoietin on normal and neoplastic cells;Elliott;Biol Targets Ther.,2012

5. Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2;Hewitson;Methods Enzymol,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP